Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
AR protein | 10 | 0 | 0 | 10 |
glucocorticoid receptor [Homo sapiens] | 11 | 0 | 0 | 11 |
thyroid hormone receptor beta isoform a | 5 | 0 | 0 | 5 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
geminin | 8 | 0 | 0 | 8 |
Sex hormone-binding globulin | 0 | 0 | 2 | 2 |
Corticosteroid-binding globulin | 0 | 2 | 0 | 2 |
Mineralocorticoid receptor | 0 | 1 | 2 | 3 |
Androgen receptor | 0 | 1 | 0 | 1 |
Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 0 | 0 | 1 |
Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
TDP1 protein | 6 | 0 | 0 | 6 |
estrogen nuclear receptor alpha | 13 | 0 | 0 | 13 |
peroxisome proliferator activated receptor gamma | 5 | 0 | 0 | 5 |
ATP-binding cassette sub-family C member 3 | 0 | 5 | 0 | 5 |
Multidrug resistance-associated protein 4 | 0 | 5 | 0 | 6 |
Bile salt export pump | 0 | 10 | 0 | 10 |
Cellular tumor antigen p53 | 6 | 0 | 0 | 6 |
Thromboxane-A synthase | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
Prostacyclin receptor | 0 | 1 | 1 | 2 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
Canalicular multispecific organic anion transporter 1 | 0 | 5 | 0 | 5 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 2B1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 3A1 | 0 | 0 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 2 | 0 | 0 | 2 |
peripheral myelin protein 22 | 5 | 0 | 0 | 5 |
Translocator protein | 0 | 0 | 1 | 1 |
Vasopressin V2 receptor | 0 | 2 | 1 | 4 |
Oxytocin receptor | 0 | 1 | 1 | 2 |
Vasopressin V1a receptor | 0 | 0 | 2 | 2 |
Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
Vasopressin V2 receptor | 0 | 0 | 1 | 1 |
Vasopressin V1b receptor | 0 | 1 | 1 | 3 |
Translocator protein | 0 | 1 | 0 | 2 |
Oxytocin receptor | 0 | 1 | 0 | 1 |
Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 6 | 0 | 0 | 6 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 3 | 0 | 0 | 3 |
Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
Chain A, 2-oxoglutarate Oxygenase | 3 | 0 | 0 | 3 |
GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
ras protein, partial | 0 | 0 | 1 | 1 |
interleukin 8 | 1 | 0 | 0 | 1 |
thioredoxin reductase | 5 | 0 | 0 | 5 |
GLS protein | 4 | 0 | 0 | 4 |
aldehyde dehydrogenase 1 family, member A1 | 4 | 0 | 0 | 4 |
thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 7 | 0 | 0 | 7 |
EWS/FLI fusion protein | 6 | 0 | 0 | 6 |
retinoic acid nuclear receptor alpha variant 1 | 9 | 0 | 0 | 9 |
estrogen-related nuclear receptor alpha | 10 | 0 | 0 | 10 |
cytochrome P450 2D6 | 5 | 0 | 0 | 5 |
glucocerebrosidase | 1 | 0 | 0 | 1 |
peroxisome proliferator-activated receptor delta | 3 | 0 | 0 | 3 |
Rac1 protein | 0 | 0 | 1 | 1 |
IDH1 | 1 | 0 | 0 | 1 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 7 | 0 | 0 | 7 |
Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 6 | 0 | 0 | 6 |
DNA polymerase kappa isoform 1 | 4 | 0 | 0 | 4 |
muscarinic acetylcholine receptor M1 | 4 | 0 | 0 | 4 |
lethal factor (plasmid) | 2 | 0 | 0 | 2 |
Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 3 | 0 | 4 |
Carbonic anhydrase 2 | 0 | 3 | 0 | 4 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Integrin beta-3 | 0 | 1 | 0 | 1 |
Myeloperoxidase | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
Integrin alpha-IIb | 0 | 1 | 0 | 1 |
Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 3 | 0 | 4 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Urotensin-2 receptor | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 1 | 0 | 0 | 1 |
Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 2 | 1 | 0 | 3 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 1 | 3 |
Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
Cytochrome P450 3A4 | 0 | 3 | 0 | 3 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Chain A, Beta-lactamase | 5 | 0 | 0 | 5 |
acetylcholinesterase | 5 | 0 | 0 | 5 |
USP1 protein, partial | 6 | 0 | 0 | 6 |
NFKB1 protein, partial | 2 | 0 | 0 | 2 |
nonstructural protein 1 | 2 | 0 | 0 | 2 |
arylsulfatase A | 1 | 0 | 0 | 1 |
transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 8 | 0 | 0 | 8 |
cytochrome P450 3A4 isoform 1 | 2 | 0 | 0 | 2 |
lamin isoform A-delta10 | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit pi | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-2 | 2 | 0 | 0 | 2 |
GABA theta subunit | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit epsilon | 2 | 0 | 0 | 2 |
ATP-dependent phosphofructokinase | 5 | 0 | 0 | 5 |
ORF73 | 0 | 0 | 1 | 1 |
chromobox protein homolog 1 | 6 | 0 | 0 | 6 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 3 | 0 | 0 | 3 |
Cytochrome P450 2C8 | 0 | 2 | 0 | 2 |
Cytochrome P450 2B6 | 0 | 3 | 0 | 3 |
Liver carboxylesterase 1 | 0 | 0 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
Cytochrome P450 2C19 | 0 | 3 | 0 | 3 |
Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
pregnane X receptor | 2 | 0 | 0 | 2 |
GALC protein | 1 | 0 | 0 | 1 |
retinoid X nuclear receptor alpha | 4 | 0 | 0 | 4 |
farnesoid X nuclear receptor | 5 | 0 | 0 | 5 |
pregnane X nuclear receptor | 7 | 0 | 0 | 7 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 5 | 0 | 0 | 5 |
nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
glycogen synthase kinase-3 alpha | 0 | 0 | 0 | 1 |
muscleblind-like protein 1 isoform 1 | 2 | 0 | 0 | 2 |
Exportin-1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 1 | 0 | 2 |
Glyceraldehyde-3-phosphate dehydrogenase | 0 | 1 | 0 | 1 |
NAD-dependent histone deacetylase SIR2 | 0 | 1 | 0 | 3 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Cytochrome P450 2A6 | 0 | 0 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Cytochrome P450 2A5 | 0 | 0 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 1 |
Glyceraldehyde-3-phosphate dehydrogenase, glycosomal | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 6 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
Quinone oxidoreductase | 0 | 0 | 0 | 1 |
Beta-secretase 1 | 0 | 1 | 0 | 1 |
Sorbitol dehydrogenase | 0 | 1 | 0 | 1 |
Induced myeloid leukemia cell differentiation protein Mcl-1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 9 | 0 | 1 | 0 | 2 |
Zn finger protein | 0 | 1 | 0 | 1 |
Dihydroorotate dehydrogenase | 0 | 2 | 0 | 2 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 1 |
G | 3 | 0 | 0 | 3 |
Solute carrier family 22 member 2 | 0 | 3 | 0 | 4 |
Prothrombin | 0 | 3 | 0 | 3 |
Coagulation factor X | 0 | 4 | 0 | 4 |
Plasminogen | 0 | 1 | 0 | 1 |
Coagulation factor XII | 0 | 2 | 0 | 2 |
Tissue-type plasminogen activator | 0 | 1 | 0 | 1 |
Interferon beta | 5 | 0 | 0 | 5 |
HLA class I histocompatibility antigen, B alpha chain | 3 | 0 | 0 | 3 |
Vitamin K-dependent protein C | 0 | 1 | 0 | 1 |
Serine protease hepsin | 0 | 1 | 0 | 1 |
Trypsin-1 | 0 | 1 | 0 | 1 |
Trypsin-2 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 1 | 0 | 1 |
Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 2 | 0 | 2 |
Trypsin-3 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 2 | 0 | 2 | 0 | 2 |
Inositol hexakisphosphate kinase 1 | 3 | 0 | 0 | 3 |
Multidrug and toxin extrusion protein 1 | 0 | 3 | 0 | 3 |
cytochrome P450 2C9, partial | 3 | 0 | 0 | 3 |
hypoxia-inducible factor 1 alpha subunit | 2 | 0 | 0 | 2 |
RAR-related orphan receptor gamma | 6 | 0 | 0 | 6 |
SMAD family member 2 | 3 | 0 | 0 | 3 |
SMAD family member 3 | 3 | 0 | 0 | 3 |
GLI family zinc finger 3 | 5 | 0 | 0 | 5 |
estrogen receptor 2 (ER beta) | 3 | 0 | 0 | 3 |
progesterone receptor | 4 | 0 | 0 | 4 |
aryl hydrocarbon receptor | 3 | 0 | 0 | 3 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 3 | 0 | 0 | 3 |
thyroid stimulating hormone receptor | 6 | 0 | 0 | 6 |
thyroid hormone receptor beta isoform 2 | 5 | 0 | 0 | 5 |
heat shock protein beta-1 | 3 | 0 | 0 | 3 |
Beta-glucuronidase | 0 | 1 | 0 | 1 |
Beta-glucuronidase | 0 | 1 | 0 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 2 | 0 | 2 |
Alpha-synuclein | 1 | 0 | 0 | 1 |
TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
G-protein coupled bile acid receptor 1 | 0 | 0 | 1 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
NPC1-like intracellular cholesterol transporter 1 | 0 | 0 | 1 | 1 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
ATAD5 protein, partial | 4 | 0 | 0 | 4 |
caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
nuclear receptor subfamily 1, group I, member 3 | 5 | 0 | 0 | 5 |
caspase-3 | 2 | 0 | 0 | 2 |
Histone H2A.x | 3 | 0 | 0 | 3 |
Caspase-7 | 1 | 0 | 0 | 1 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
caspase-3 | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
Voltage-dependent calcium channel gamma-2 subunit | 2 | 0 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 5 | 0 | 5 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
Alpha-2B adrenergic receptor | 0 | 4 | 0 | 4 |
Alpha-2C adrenergic receptor | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
Alpha-2B adrenergic receptor | 0 | 1 | 1 | 2 |
Glutamate receptor 2 | 2 | 0 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 0 | 2 | 0 | 2 |
Alpha-2C adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-2A adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-1D adrenergic receptor | 0 | 0 | 1 | 1 |
Alpha-1D adrenergic receptor | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 0 | 1 | 1 |
Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 2 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
Ataxin-2 | 2 | 0 | 0 | 2 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 5 | 0 | 0 | 5 |
Luciferase | 2 | 0 | 0 | 2 |
PPM1D protein | 2 | 0 | 0 | 2 |
DNA polymerase beta | 3 | 0 | 0 | 3 |
flap endonuclease 1 | 1 | 0 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
histone acetyltransferase KAT2A isoform 1 | 3 | 0 | 0 | 3 |
Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 1 | 0 | 1 |
Lysine-specific histone demethylase 1A | 0 | 3 | 0 | 3 |
Aurora kinase B | 0 | 1 | 0 | 1 |
67.9K protein | 1 | 0 | 0 | 1 |
Neuraminidase | 0 | 3 | 0 | 3 |
bromodomain adjacent to zinc finger domain 2B | 3 | 0 | 0 | 3 |
carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 | 0 | 1 | 0 | 1 |
Calmodulin-1 | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
Nischarin | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 2 | 0 | 2 |
Heparanase | 0 | 0 | 1 | 1 |
Spike glycoprotein | 4 | 0 | 0 | 4 |
glp-1 receptor, partial | 2 | 0 | 0 | 2 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 4 | 0 | 0 | 4 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 3 | 0 | 0 | 3 |
lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
Polyphenol oxidase 2 | 0 | 2 | 0 | 2 |
Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Cholesteryl ester transfer protein | 0 | 1 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 3 | 1 | 4 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
D-amino-acid oxidase | 0 | 1 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 2 | 0 | 2 |
Hydroxycarboxylic acid receptor 3 | 0 | 0 | 1 | 1 |
Nicotinamidase | 0 | 1 | 0 | 1 |
Hydroxycarboxylic acid receptor 2 | 0 | 0 | 1 | 1 |
Hydroxycarboxylic acid receptor 2 | 0 | 2 | 1 | 3 |
D-aspartate oxidase | 0 | 1 | 0 | 1 |
Hydroxycarboxylic acid receptor 2 | 0 | 1 | 1 | 2 |
apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
Cytochrome P450 2D6 | 0 | 2 | 0 | 2 |
Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
Protease | 0 | 3 | 0 | 3 |
phosphopantetheinyl transferase | 1 | 0 | 0 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | 2 | 0 | 0 | 2 |
huntingtin isoform 2 | 1 | 0 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 1 | 0 | 0 | 1 |
cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
Chain A, Activated Factor Xa Heavy Chain | 0 | 1 | 0 | 1 |
Suppressor of tumorigenicity 14 protein | 0 | 1 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
Genome polyprotein | 0 | 1 | 0 | 1 |
Microtubule-associated protein tau | 1 | 0 | 0 | 1 |
thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
mitogen-activated protein kinase 1 | 1 | 0 | 0 | 1 |
L-lactate dehydrogenase A chain | 0 | 1 | 0 | 1 |
Chymotrypsinogen A | 0 | 1 | 0 | 1 |
Albumin | 0 | 1 | 0 | 1 |
Neuraminidase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Sialidase | 0 | 1 | 0 | 1 |
Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 1 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
Prolyl endopeptidase | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 10 | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Neuromedin-U receptor 2 | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 3 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 3 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 3 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 0 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 4 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 4 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 4 | 0 | 0 | 0 | 1 |
Chain A, Ferritin light chain | 2 | 0 | 0 | 2 |
cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
Bile salt export pump | 0 | 1 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
Albumin | 0 | 0 | 1 | 1 |
Albumin | 0 | 0 | 1 | 1 |
Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |